Peaky Blinders: The Immortal Man – A Return to Form for the Shelby Saga
The world of the Peaky Blinders returns to the screen with Peaky Blinders: The Immortal Man, a 2026 continuation of the acclaimed British television series. Directed by Tom Harper and written by Steven Knight, the film promises a gripping narrative set against the backdrop of World War II, blending the series’ signature crime drama with a historical crisis.
Plot and Premise
The film’s plot centers around a chilling scheme by Nazi Germany to destabilize the British economy. This involves utilizing Jewish concentration camp labor to produce counterfeit British pound notes. The narrative unfolds with the German Luftwaffe bombing the BSA factory in Compact Heath, Birmingham. Meanwhile, Thomas Shelby, haunted by the loss of his daughter Ruby, seeks solace in writing a novel in a rural retreat, assisted only by Johnny Dogs.
Cast and Crew
Peaky Blinders: The Immortal Man boasts a stellar ensemble cast, bringing back familiar faces alongside exciting novel additions. Cillian Murphy reprises his iconic role as Thomas Shelby, leading a cast that includes:
- Sophie Rundle
- Ned Dennehy
- Packy Lee
- Ian Peck
- Stephen Graham
- Rebecca Ferguson
- Tim Roth
- Jay Lycurgo
- Barry Keoghan
The film is produced by Steven Knight, Cillian Murphy, Guy Heeley, Caryn Mandabach, and Jimmy Tandel. George Steel serves as the cinematographer, with editing by Mark Eckersley and a musical score composed by Antony Genn and Martin Slattery.
Release Details
Peaky Blinders: The Immortal Man premiered at Symphony Hall, Birmingham on March 2, 2026. It was released in select cinemas in the United Kingdom on March 6, 2026, and globally on Netflix on March 20, 2026. The film has a running time of 112 minutes.
Production Companies
The film is a collaboration between Garrison Drama, Nebulastar, and BBC Film, and is distributed by Netflix.
Behind the Scenes
A trailer released in February 2026 highlights Tommy Shelby’s enduring and complex nature, hinting at a story that explores themes of mortality and legacy.